Pui San Wong

The Fc-mediated effector functions of a potent SARS-CoV-2 neutralizing antibody, SC31, isolated from an early convalescent COVID-19 patient, are essential for the optimal therapeutic efficacy of the antibody

Conrad En Zuo Chan, Shirley G. K. Seah, De Hoe Chye et al. · PLoS ONE · 2021 · 106 citations · Full text

Pharmacy, Immunology, Infectious Diseases +17

<scp>IDentif</scp> . <scp>AI</scp> : Rapidly optimizing combination therapy design against severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐Cov‐2) with digital drug development

Agata Blasiak, Jhin Jieh Lim, Shirley Gek Kheng Seah et al. · Bioengineering & Translational Medicine · 2020 · 44 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +16

A systems-based approach to analyse the host response in murine lung macrophages challenged with respiratory syncytial virus

Laxmi Iyer Ravi, Liang Li, Richard Sutejo et al. · BMC Genomics · 2013 · 37 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Increased hydroxymethylglutaryl coenzyme A reductase activity during respiratory syncytial virus infection mediates actin dependent inter-cellular virus transmission

Laxmi Iyer Ravi, Li Liang, Pui San Wong et al. · Antiviral Research · 2013 · 36 citations

Life Sciences, Infectious Diseases, Molecular Biology +13

The Fc-mediated effector functions of a potent SARS-CoV-2 neutralizing antibody, SC31, isolated from an early convalescent COVID-19 patient, are essential for the optimal therapeutic efficacy of the antibody

Conrad En Zuo Chan, Shirley G. K. Seah, De Hoe Chye et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 32 citations · Full text

Pharmacy, Immunology, Infectious Diseases +17